SRPT•benzinga•January 13, 2025 at 05:26 PM

Sarepta Announces Q4 2024 Revenue Of $638.2M, Exceeding Guidance; ELEVIDYS Revenue At $384.2M; RNA PMO Revenue At $254M; FY24 Revenue Totals $1.79B; $1.5B In Cash And Investments At Year-End 2024; Reiterates 2025 Revenue Guidance Of $2.9B-$3.1B

No summary available.

Read the full article from the original source for complete details and context.

Article published on January 13, 2025 by benzinga